Publication
Increased, homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease
| dc.contributor.author | Castro, R | |
| dc.contributor.author | Rivera, I | |
| dc.contributor.author | Struys, EA | |
| dc.contributor.author | Jansen, EEW | |
| dc.contributor.author | Ravasco, P | |
| dc.contributor.author | Camilo, ME | |
| dc.contributor.author | Blom, HJ | |
| dc.contributor.author | Jakobs, C | |
| dc.contributor.author | de Almeida, IT | |
| dc.date.accessioned | 2015-12-30T10:17:47Z | |
| dc.date.available | 2015-12-30T10:17:47Z | |
| dc.date.issued | 2003 | |
| dc.description.abstract | Background: The pathogenic mechanism of homocysteine's effect on cardiovascular risk is poorly understood. Recent studies show that DNA hypomethylation induced by increases in S-adenosylhomocysteine (AdoHcy), an intermediate of Hcy metabolism and a potent | |
| dc.format | application/pdf | |
| dc.identifier.citation | CLINICAL CHEMISTRY. - Vol. 49, n. 8 (AUG 2003), p. 1292-1296 | |
| dc.identifier.issn | 0009-9147 | |
| dc.identifier.uri | http://hdl.handle.net/10451/21242 | |
| dc.language.iso | eng | |
| dc.publisher | AMER ASSOC CLINICAL CHEMISTRY | |
| dc.subject | Medical Laboratory Technology | |
| dc.title | Increased, homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease | |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 1296 | por |
| oaire.citation.startPage | 1292 | por |
| oaire.citation.title | CLINICAL CHEMISTRY | por |
| oaire.citation.volume | Vol. 49 | por |
| rcaap.rights | restrictedAccess | |
| rcaap.type | article |